Somewhat Positive News Coverage Somewhat Unlikely to Impact T2 Biosystems (TTOO) Stock Price

Media headlines about T2 Biosystems (NASDAQ:TTOO) have trended somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. T2 Biosystems earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.8423177776759 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

TTOO has been the subject of several recent analyst reports. ValuEngine upgraded shares of T2 Biosystems from a “strong sell” rating to a “sell” rating in a research report on Monday. HC Wainwright set a $8.00 price target on shares of T2 Biosystems and gave the company a “buy” rating in a research report on Monday, February 12th. Goldman Sachs began coverage on shares of T2 Biosystems in a research report on Monday, January 29th. They issued a “neutral” rating and a $5.20 price target for the company. Finally, Zacks Investment Research downgraded shares of T2 Biosystems from a “buy” rating to a “hold” rating in a research report on Saturday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. T2 Biosystems has a consensus rating of “Hold” and an average target price of $5.66.

Shares of T2 Biosystems stock opened at $6.52 on Thursday. T2 Biosystems has a 12-month low of $2.50 and a 12-month high of $7.26. The company has a market cap of $248.90, a price-to-earnings ratio of -3.43 and a beta of 1.49. The company has a debt-to-equity ratio of 2.25, a current ratio of 5.40 and a quick ratio of 5.28.

COPYRIGHT VIOLATION NOTICE: This story was first reported by BBNS and is the property of of BBNS. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://baseballnewssource.com/2018/03/22/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-t2-biosystems-ttoo-stock-price/1925696.html.

T2 Biosystems Company Profile

T2 Biosystems, Inc is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company’s T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL).

Insider Buying and Selling by Quarter for T2 Biosystems (NASDAQ:TTOO)

Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Bryce Harper Hits 406-Foot Home Run While Breaking His Bat
Rick Porcello’s Strong Start Gives Boost to Red Sox
Rick Porcello’s Strong Start Gives Boost to Red Sox
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Two Bench Clearing Incidents Revive Red Sox-Yankees Rivalry
Xander Bogaerts Goes on Red Sox DL
Xander Bogaerts Goes on Red Sox DL
Ohtani Goes Deep in Third Straight Game for Angels
Ohtani Goes Deep in Third Straight Game for Angels
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies
Charlie Blackmon Agrees to Contract Extension with Colorado Rockies


Leave a Reply

 
© 2006-2018 BBNS.